临床试验/NCT00770523

NCT00770523已完成不适用

Unrelated Donor Hematopoietic Stem Cell Transplantation After Nonmyeloablative Conditioning for Younger Patients With Hematologic Malignancies

Cooperative Study Group A for Hematology1 个研究点分布在 1 个国家目标入组 52 人开始时间: 2003年12月最近更新: 2011年6月10日

适应症

试验速览

阶段: 不适用
状态: 已完成
发起方
入组人数: 52
试验地点: 1
主要终点: treatment-related mortality and engraftment

研究概览研究设计入排标准结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

Unrelated Donor Hematopoietic Stem Cell Transplantation After Nonmyeloablative Conditioning for Younger Patients with Hematologic Malignancies.

详细描述

Primary end points are treatment-related mortality and engraftment. Secondary end points are regimen-related toxicities, graft-versus-host-disease, relapse, and overall survival.

研究设计

研究类型: Observational
观察模型: Case Only
时间视角: Prospective

入排标准

年龄范围: 15 Years 至 55 Years（Child, Adult）
性别: All
接受健康志愿者: 否

入选标准

•Patients should have an unrelated donor who is matched for HLA-A and -B by serology and for -DRB1 by molecular typing.

排除标准

•Patients should not have major illness or organ failure
•Patients must not have a psychiatric disorder or mental deficiency severe as to make compliance with the treatment unlike, and making informed consent impossible.
•Patients must not be pregnant or lactating.

结局指标

主要结局

treatment-related mortality and engraftment

时间窗: all cause mortality

次要结局

regimen-related toxicities, graft-versus-host-disease, relapse, and overall survival.(Time point(s) at which outcome measure is assessed.)

研究者

发起方

Cooperative Study Group A for Hematology

申办方类型

Network

研究点 (1)

Loading locations...

相似试验

进行中（未招募）

不适用

onmyeloablative Hematopoietic Stem Cell Transplantation for Patients with High-Risk Hematologic Malignancies using Related, HLA-Haploidentical Donors: A Phase II Trial of Combined Immunosuppression with cyclophosfamide administered Before and After Transplantation. A monocentric study. - NDHigh risk Hematologic MalignanciesMedDRA version: 9.1Level: HLGTClassification code 10024324MedDRA version: 9.1Level: HLGTClassification code 10025323

EUCTR2009-018083-94-ITISTITUTO EUROPEO DI ONCOLOGIA

招募中

1 期

Blood Stem Cell transplantation with low dose chemo/radiotherapy for patients with High-Risk solid tumors using related identical donors or 50% compatible donors

EUCTR2012-002464-27-ITISTITUTO EUROPEO DI ONCOLOGIA20

进行中（未招募）

1 期

Stem cells transplant from matched donor in patients with chronic myeloid leukemia who do not improve with TKI therapyChronic Myeloid LeukemiaMedDRA version: 18.0Level: LLTClassification code 10054352Term: Chronic phase chronic myeloid leukemiaSystem Organ Class: 100000004864

EUCTR2014-003126-40-ITIVERSITà DEGLI STUDI MILANO BICOCCA20

已完成

不适用

Stem Cell Transplant From Matched Unrelated or Partially Matched Related DonorsBlood CancerBlood and Marrow Transplant (BMT)

NCT00186225Stanford University250

终止

2 期

Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic CancerChronic Myeloproliferative DisordersMultiple Myeloma and Plasma Cell NeoplasmLymphomaLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative NeoplasmsUnusual Cancers of Childhood

NCT00281879OHSU Knight Cancer Institute200